
Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL
Description
About Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL
The Human Cyclin-dependent kinase 4 Peptide (IEDB: 442354) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Cyclin-dependent kinase Peptide, H-ALTPVVVTL-OH (Uniprot: P11802 aa: 170-178) from JPT is produced under strict quality control and quality management.
Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL - Specifications
- Peptide sequence: H-ALTPVVVTL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Leukemia
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL
References:
Read References with JPT’s Antigen Peptides
Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL has been described in:
Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire., Cancer Immunol Res, 2015 (PMID: 25576336)
An open-source computational and data resource to analyze digital maps of immunopeptidomes., Elife, 2015 (PMID: 26154972)
Generation of novel complete HLA class I monoallelic cell lines used in an MHC stabilization assay for neoantigen evaluation., Oncol Lett, 2023 (PMID: 37415627)
Documentation
Documentation for Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL
Properties
Properties of Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Leukemia |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Cyclin-dependent kinase 4 170-178, ALTPVVVTL
Information | Values |
---|---|
Sequence: | H-ALTPVVVTL-OH |
Specifications: | 9mer peptide as TFA salt |